Exposing the Deep State: Kennedy Takes a Stand Against Regulatory Corruption

In a recent meeting with FDA officials, Robert F. Kennedy Jr. highlighted the pervasive corruption within federal agencies, aiming for increased transparency and accountability. He criticized the FDA's GRAS system and called for a thorough review while suggesting that every agency is tainted by industry influence. With Kennedy now in a critical position, he pushes for real oversight to protect public interests over corporate profits.

In a bold move that has reverberated through U.S. politics, Health and Human Services Secretary Robert F. Kennedy Jr. has voiced his strong criticism of what he believes to be deep-rooted corruption within America’s regulatory agencies. During a recent private meeting with FDA staff, including new Commissioner Marty Makary, Kennedy aligned himself with former President Donald Trump's long-held assertions regarding the existence of a “Deep State,” a term referring to the undemocratic influence of unelected officials in government.

Leaked transcripts from the closed-door session, reported by Politico, reveal Kennedy's perspective that the government’s shadowy control comes not only from notorious figures like George Soros and Bill Gates, but also from an intricate web of bureaucrats and corporate interests that operate just beneath the surface, effectively steering national policy away from the public interest.

Kennedy's specific criticism was directed at the FDA’s “Generally Recognized as Safe” (GRAS) system. He described it as a critical gap that permits food companies to avoid comprehensive safety evaluations for newly introduced ingredients. He mandated a comprehensive review of the GRAS system back in March, articulating a need for genuine oversight and transparency rather than rushed approvals that primarily benefit large corporations.

The Secretary did not hold back in his assertion that the issues of regulatory capture were widespread, stating to NBC News that this challenge isn’t confined merely to the FDA—“every agency” is similarly compromised. Throughout his 2024 campaign, Kennedy has consistently underscored the importance of exposing bureaucratic corruption, even going as far as warning FDA employees to “preserve your records and pack your bags” if they find themselves part of the corrupt system.

With Trump’s return to the White House alongside Kennedy's influential role at HHS, the pair is committed to not just discussing reforms but taking tangible steps to cleanse the agencies designed to safeguard public health, prioritizing citizens’ safety over corporate profits.